Recent research on intermittent fasting has shown promising results in terms of weight loss and reducing the risk of dementia. However, a new study in mice has shed light on a potential downside of periodic food abstinence – an increased risk of cancer. This discovery adds a new layer of complexity to the debate on the benefits and risks of fasting.
The study reveals that fasting in mice led to a boost in the regenerative capabilities of their intestinal stem cells, which can protect against injury and inflammation. However, the increase in stem cell production accelerates when mice refeed after fasting. This post-fasting period is when the risk of cancer may be heightened due to the introduction of mutagens, such as heterocyclic amines found in burned meats, which can cause genetic mutations and increase the risk of cancerous tumors.
Intestinal stem cells are known to be amongst the most active in the body, constantly dividing and growing to reline the intestine every 5 to 10 days. This high level of activity also makes these cells more susceptible to cancer-causing aberrations. The study identified a biological pathway called mTOR, which plays a crucial role in cell growth and metabolism. After fasting, this pathway increases the production of polyamines, which drive cell proliferation and aid in the body’s recovery and regeneration.
The researchers found that fasting and refeeding represent two distinct states in the body. In the fasted state, cells are able to use lipids and fatty acids as an energy source to survive when nutrients are low. It is during the postfast refeeding state that regeneration is accelerated. However, this period also increases the probability of tumors, especially in conditions conducive to cancer growth.
Previous studies have suggested that fasting and fasting-mimicking diets could potentially reduce the risk of cancer and enhance the effectiveness of anti-cancer therapies. However, these studies have mainly focused on the benefits of abstaining from food without considering the potential risks associated with breaking the fast. Further research is needed to explore ways to maximize the benefits of fasting while minimizing the risks.
It is important to note that the study was conducted on mice with specific cancer mutations, and the findings may not directly translate to humans. More research is needed to fully understand the implications of intermittent fasting on cancer risk in humans. As biologist Omer Yilmaz emphasizes, additional studies are required to deepen our understanding of the complex relationship between fasting and cancer risk.
While intermittent fasting has been hailed for its potential health benefits, the latest research suggests a potential downside in terms of cancer risk. The study highlights the importance of further investigation into the effects of fasting and refeeding, as well as the need for caution in interpreting the results of animal studies. As we continue to unravel the complexities of fasting and its impact on health, it is essential to consider both the positives and negatives of this dietary approach.
Leave a Reply